2894733-91-4
Chemical Structure
PD-L1-IN-2
- CAS No.: 2894733-91-4
- Formula:C33H38N4O6
- Molecular Weight:586.68
IUPAC Name: tert-butyl (3-((5-(3,4-dimethoxybenzyl)-4-(4-methoxybenzyl)-1-methyl-1H-imidazol-2-yl)carbamoyl)phenyl)carbamate
InChIKey: WCBUHIGCYKSAAG-UHFFFAOYSA-N
SMILES: COC1=CC=C(CC2=C(CC3=CC(OC)=C(OC)C=C3)N(C)C(NC(C4=CC(NC(OC(C)(C)C)=O)=CC=C4)=O)=N2)C=C1
Biological Activity: PD-L1-IN-2 is a potential tumor immunological agent by inhibiting PD-L1. PD-L1-IN-2 is a Naamidine J derivative and exerts antitumor effects in vivo by reducing PD-L1 expression and enhancing tumor-infiltrating T-cell immunity. PD-L1-IN-2 is used for colorectal cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PD-L1-IN-2 | 99.41% | PD-L1-IN-2 is a potential tumor immunological agent by inhibiting PD-L1. PD-L1-IN-2 is a Naamidine J derivative and exerts antitumor effects in vivo by reducing PD-L1 expression and enhancing tumor-infiltrating T-cell immunity. PD-L1-IN-2 is used for colorectal cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
